Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
|
|
Intersect ENT, Inc. (XENT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/31/2022 |
SC 13G
| GOLDMAN SACHS GROUP INC reports a 7.9% stake in INTERSECT ENT, INC. |
| 10/20/2021 |
SC 13G
| INTEGRATED CORE STRATEGIES LLC reports a 4.9% stake in INTERSECT ENT, INC. |
| 08/17/2021 |
SC 13G
| Versor Investments LP reports a 5.2% stake in INTERSECT ENT, INC. |
| 02/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/08/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/11/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/22/2019 |
SC 13G
| PURA VIDA INVESTMENTS, LLC reports a 5.2% stake in Intersect ENT, Inc. |
| 05/10/2019 |
SC 13G
| Point72 Asset Management, L.P. reports a 5.4% stake in Intersect ENT, Inc. |
| 02/15/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/13/2018 |
SC 13G
| HealthCor Management, L.P. reports a 6.4% stake in Intersect ENT, Inc. |
| 08/03/2018 |
SC 13G
| Flynn James E reports a 7% stake in Intersect ENT, Inc. |
| 11/16/2017 |
SC 13G
| Flynn James E reports a 5.9% stake in Intersect ENT, Inc. |
| 01/30/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|